top of page
Image by Hans Reniers

PIPELINE

Candidate R&D

Preclinical

Clinical Phase 1/2

Technology Tranfer

Clinical Phase 3

Product Sales

Candidate R&D
Discovery and Acquisition

Preclinical

Clinical Phase 1/2

Clinical Phase 3

Product Sales

Technology Tranfer / M&A

Candidate R&D

Candidate R&D

Preclinical

Preclinical

Clinical Phase 1/2

Clinical Phase 1/2

Clinical Phase 3

Product Sales

Technology Tranfer

Clinical Phase 3

Product Sales

Technology Tranfer

R&D stage

Promotion year

Promotion contents

Promotion schedule

2022

2023

2024

2025

One     2     3     4     5     6     7     8     9   10   11   12

6 types of Dimeric including CarBio-101, 102 lymphoma, CarBio-201 pancreatic cancer

CAR vector production (consignment)

6 types including CarBio-101, 102 lymphoma, CarBio-201 pancreatic cancer

Verification and tri-category

3 types including CarBio-101, 102 lymphoma, CarBio-201 pancreatic cancer

Screening and building in vitro assays

CarBio-101, 102 lymphoma, CarBio-201 3 types of pancreatic cancer

in vitro efficacy test

CarBio-101 and -102 lymphoma, CarBio-201 3 types of pancreatic cancer

Biodistribution/toxicity safety test

CarBio-202 Breast/ovarian cancer CarBio-201 Pancreatic cancer

CarBio-201 CarBio-202 non-clinical trial

CarBio-101 and -102 Clinical Trial Preparation

CarBio-101 and -102 2 types of IND application

CarBio-301 Candidates for head and neck cancer

CarBio-301 head and neck cancer non-clinical trial

CarBio-302 Lung Cancer and -401 Dementia Candidates

CarBio-302 lung cancer non-clinical trial

CarBio-101 and -102 lymphoma, CarBio-201 3 types of pancreatic cancer, and

In vitro/in vivo preparation

CarBio-103 Lupus treatment in vitro efficacy test

Non-clinical trial of CarBio-103 Lupus treatment

CarBio-101 and -102 lymphoma, three types of CarBio-201 pancreatic cancer in vivo

Animal model efficacy test

2026

CarBio-101 and -102 type 2 clinical trial phase 2

CarBio-201 and -202 2 types IND

CarBio-301 and -302 IND

CarBio-401 non-clinical

bottom of page